Table 3.
Day 1 | Day 2 | Day 3 |
---|---|---|
5HT-3 receptor antagonista | ||
Dexamethasone 12 mg PO/IV | Dexamethasone 8 mg PO daily | Dexamethasone 8 mg PO daily |
See text for alternative schemes
aPalonosetron is advised because of its superiority
Day 1 | Day 2 | Day 3 |
---|---|---|
5HT-3 receptor antagonista | ||
Dexamethasone 12 mg PO/IV | Dexamethasone 8 mg PO daily | Dexamethasone 8 mg PO daily |
See text for alternative schemes
aPalonosetron is advised because of its superiority